We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Life Technologies and DaAn Gene Form Joint Diagnostic Business

By LabMedica International staff writers
Posted on 30 Jan 2012
Life Technologies (Carlsbad, CA, USA) has signed an agreement with DaAn Gene (Guangzhou, China), a leading company in molecular in vitro diagnostics (IVD), to form Life Technologies DaAn Diagnostics (Guangzhou, China), a joint venture diagnostics business. More...
Financial terms of the deal were not disclosed.

Life Technologies DaAn Diagnostics will develop and commercialize a portfolio of molecular diagnostic assays using Life Technologies' 3500Dx capillary electrophoresis instrument and the Big Dye Cycle Sequencing technologies, focused on IVD assays for oncology, infectious, and genetic diseases. The joint venture allows both companies to expand the use of capillary electrophoresis technology into the Chinese clinical diagnostics market.

The 3500Dx instrument is a capillary-based Sanger Sequencer intended for use in the analysis of human DNA for the detection of genetic changes that indicate disease presence or improved response to various therapies. The genetic analyzer was approved by China's State Food and Drug Administration (SFDA) for IVD diagnostic use in China in October 2011.

"The joint venture will help us offer leading medical diagnostic technologies with cost-effective solutions to Chinese healthcare professionals," said Dr. Siddhartha Kadia, president of Life Technologies, Greater China. "This approach leverages our expertise in platform development and DaAn's expertise in regulated markets with kit development and commercialization."

DaAn Gene Co., Ltd. of Sun Yat-sen University (Guangzhou, China) is a biotech enterprise focused on molecular diagnostic techniques. With the Certificate of Good manufacturing practice (GMP), DAAN Gene is committed to R&D, production, and service of in vitro diagnostic products.

Life Technologies is a global biotechnology company whose systems, consumables, and services enable scientists to accelerate scientific and medical advancements to improve human health. The company manufactures both molecular diagnostic and research use only products.

Related Links:
Life Technologies
DaAn Gene
Sun Yat-sen University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.